# Zimmer Biomet Holdings, Inc. – Consensus ‘hold’ rating and 27.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/zimmer-biomet-holdings-inc.consensus-hold-rating-and-27.8-upside-potential/4121126279
- Published: 2023-08-30T13:30:15+01:00
- Author: Charlotte Edwards

**Zimmer Biomet Holdings, Inc.** with ticker code (ZBH) now have 23 market analysts
covering the stock. The analyst consensus now points to a rating of ‘hold’. The 
target price High/Low ranges between 172 and 120 suggesting an average Analsyt target
price of $150.15. Given that the stocks previous close was at $117.53 this would
imply there is now a potential upside of 27.8%. Also worth taking note is the 50
day moving average now sits at $133.72 and the 200 day moving average is $129.30.
The company has a market capitalization of 24.91B. The stock price is currently 
at: 119.23 USD

 The potential market cap would be $31,829,779,065 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 49.68, revenue per share of 34.36
and a 4.18% return on assets.

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments
include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and 
markets orthopedic reconstructive products; sports medicine, biologics, extremities
and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical 
products; and a suite of integrated digital and robotic technologies that leverage
data, data analytics and artificial intelligence. Its other product category primarily
includes its robotic, surgical and bone cement products. Its products and solutions
help treat patients suffering from disorders of, or injuries to, bones, joints or
supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants,
Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip 
System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular 
System. Its S.E.T. product category includes sports medicine, biologics, foot and
others.

Share on: